Literature DB >> 1550636

Management of term patients with premature rupture of membranes and an unfavorable cervix.

J M Guise1, P Duff, J S Christian.   

Abstract

The purpose of this prospective investigation was to evaluate a protocol for management of term patients with premature rupture of membranes (PROM) and a cervix unfavorable for induction of labor (Bishop score 4 or less). Patients initially were observed for 24 to 36 hours for the spontaneous onset of labor. If spontaneous contractions did not commence, labor was induced with oxytocin. Patients subsequently were divided into three groups: 44 who had spontaneous labor, 29 who had spontaneous labor but required oxytocin augmentation, and 39 women who had oxytocin induction. Patients who entered labor spontaneously had a significantly shorter mean latent period between rupture of membranes and onset of labor (16.0 versus 26.8 and 40.7 hours), shorter mean duration of labor (7.6 versus 12.1 and 13.1 hours), and shorter mean duration of rupture of membranes (23.6 versus 39.0 and 53.8 hours). These women also had a significant decrease in the frequency of chorioamnionitis (7 versus 14 and 33%), and their infants had fewer evaluations for sepsis (25.0 versus 34.5 and 53.8%). We conclude that term patients with PROM and an unfavorable cervix who require oxytocin augmentation or induction of labor are at increased risk for intrapartum and neonatal infection compared with those who progress through labor spontaneously.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1550636     DOI: 10.1055/s-2007-994671

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  2 in total

1.  Premature rupture of membranes at term: a medical and economic rationale for active management.

Authors:  P Duff
Journal:  CMAJ       Date:  1997-12-01       Impact factor: 8.262

Review 2.  Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more).

Authors:  Philippa Middleton; Emily Shepherd; Vicki Flenady; Rosemary D McBain; Caroline A Crowther
Journal:  Cochrane Database Syst Rev       Date:  2017-01-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.